I generally don't trust cancer-communication if it's juiced up like this incredible headline. There has been huge amounts of progress. We don't need silicon valley idiots starting to make proclamations. It's doing fine without your mediocrity.

Sounds a little too close, in both name and concept, to Therac for my comfort.

Theryq - why would they go with this name when everyone in the field knows about the Therac-25 radiation overexposure incidents?

Hey, FLASH finally hit Hacker News! I remember my professors talking about this in graduate school. It's a fairly well-established effect: the tumor selectivity of radiation is much better at ultra-high dose rates. It is still unclear exactly why. But there are a lot of studies about it:

https://www.nature.com/articles/s41571-022-00697-z